var addy_text67623 = 'info' + '@' + 'igbamedicines' + '.' + 'org'; Breckenridge Pharmaceutical, Inc. Phone: +34 93 641 10 00 28046 The CIF of TOWA PHARMA INTERNATIONAL HOLDINGS SL is B67563759 and its current trading status is active. //-->\n Towa also works with international health agencies such as the World Health Organization (WHO), Pan American Health Organization (PAHO) (the world's oldest international public health agency) and the Ministry of Health of various countries. The President of TOWA, Itsuro Yoshida, commented on the acquisition by saying:''I am happy that we can now build a foundation for full-scale overseas expansion by obtaining the sales networks that Pensa owns in Europe and the U.S., its know-how and knowledge on EMA/FDA regulations and commercial practices in each country, and its production facility in Europe. Towa was listed on Tokios stock exchange. Northbound: Daitotsurumi exit Towa Pharma International Holdings. '', Privacy Offers a wide variety of expertise encompassing Regulatory Affairs, Quality Assurance, Technical Services and Clinical Affairs, supporting Product Development through ANDA submission, approval and product launch. - Developed by sip, Our Affiliations, Accreditations and Collaboration with Other Organizations, Video: Biosimilars, a science success story, Our collaboration with other organizations. Towa Pharma International Holdings may. Natco focuses on the development and manufacturing of oncology and other specialty pharmaceuticals. Executive Officer & Deputy General Manager-Sales: Senior Executive Officer & GM-Administration: YOSHIDA FAMILY /TOWA PHARMACEUTICAL/ (39.0%), Towa Pharmaceutical Business Association (2.9%), Towa Pharmaceutical Employee Stock Ownership Plan (1.7%), Towa Pharma International Holdings SL (Sociedad Unipersonal), Towa Pharmaceutical Restricted Stock Compensation Plan, Towa Pharmaceutical Employee Stock Ownership Plan, Take your reading anywhere with offline reading functions, Never miss a story with breaking news alerts. document.write('<\/a>'); You need to accept analytics cookies to watch the video. Register a Trademark; File an International Trademark; Trademark Office Action Response; Trademark Statement of Use ; Trademark Renewal ; We are the international subsidiary for the Japanese company Towa Pharmaceutical in Europe and the United States. With our dedication to customer service, on-time delivery, reliable supply and quality manufacturing, we strive to impact the health of the patients we and our customers serve. According to industry sales data, Jevtana Kit generated annual sales of $303 million during the twelve months ending May 2022. Madrid, Spain, Information on Spanish companies: access all commercial and financial information of any company, BALLACH DERIVERA JOAN CARLES. Towa Pharma International Holdings ene. We recommend you activate this companys alerts to receive regular updates. You can consult the contact details for TOWA PHARMA INTERNATIONAL HOLDINGS SL, including its telephone number, address and website, in the Company Details module. This site is operated by a business or businesses owned by Informa PLC and all copyright resides Torre Europa, pl 16. Please fill out the form below to receive an update as soon as this new functionality is available. company changed its name to Towa Pharma International Holdings, S.L (hereinafter referred to as "Towa HD"). PTS Pharma is also involved in active raw material clinical production by fermentation technology processes. 2023/05/31 NEW Notice of the 67th Ordinary General Meeting of Shareholders 2023/05/15 NEW FY2022 Supplementary Material of Financial Results 2023/05/15 NEW Summary of Consolidated Financial Results for the Year Ended March 31, 2023 (Based on Japanese GAAP) Towa has its liaison offices in Nigeria, Tanzania, Kenya, Philippines also has country managers based in various countries in Asia Pacific, Russia CIS, Latin America and Africa. (EU/US Regional Headquarters) Protosera Inc. (Disease risk testing service business and research and development of diagnostic drugs) Sunsho Pharmaceutical Co., Ltd. (Planning, development and OEM manufacturing of health foods, pharmaceuticals, general foods and other miscellaneous merchandizes) with them. La farmacutica japonesa Towa Pharmaceutical ha alcanzado un acuerdo con la catalana Esteve para adquirir su divisin de genricos, Pensa Investments, por un total de 320 millones LTD. 2018 | Powered By -. var addy22534 = 'skox' + '@'; IGBA| INTERNATIONAL GENERICAND BIOSIMILAR MEDICINES ASSOCIATION, C/O DYN SARue de Cornavin 111201 Geneva, Switzerland, Telephone:+32 (0)477438729 (S. Kox)E-mails: Submitting innovative and personalized solutions is our key driver. At Towa, we have strong end-to-end capabilities with extensive capacities: up to 3 billion units of oral solid dosages capacity in manufacturing and packaging, fully serialization and aggregation ready.Our clients trust us on many types of projects in pharma from early stage development up to packaging services. 15 Massirio Drive, Suite 201 We contribute to people's health. From small scale, feasibility studies up to full development programs. var prefix = 'ma' + 'il' + 'to'; According to industry sales data, the product and its generics had annual sales of approximately $75 million during the twelve months ending February 2022. With a zest born out of the desire to improve health and quality of life globally, Towa started its international business operations prior to setting up manufacturing unit. Towa Pharma International Holdings nov. de 2022 - actualidad7 meses Greater Barcelona Metropolitan Area External Advisor Gate2Brain 2021 - actualidad2 aos Barcelona, Spain External Advisor. Towa Pharma International Holdings, S.L. de 2022 - actualidad1 ao 1 mes Martorelles, Catalua, Espaa Enable the company stay competitive and meet market demands by deep understanding of the. to learn how you can update your cookie settings. Towa Pharma International Holdings SL (Sociedad Unipersonal) Greencaps Pharmaceutical Co., Ltd. Towa Pharmaceutical Restricted Stock Compensation Plan Pensa Investments SL Sunsho. Your message and contact details will be sent directly to. This email address is being protected from spambots. . He is also member of the management committee of the Spanish Generic Association (AESEG) and represents Towa in the Medicines for Europe asociation. All Rights Reserved. We share its purpose, to contribute to peoples overall health and wellbeing by improving and extending life expectancy. This report is currently unavailable. Breckenridge Pharmaceutical, Inc. announces today that the U.S. Food and Drug Administration has granted approval of its Abbreviated New Drug Application for Cabazitaxel Intravenous Powder (generic for Jevtana Kit). This product was developed in collaboration with Natco Pharma Limited. You can change the configuration of your cookies by pressing "MORE INFORMATION AND CONFIGURATION". of a complex "For Suspension" product developed by PTS. document.write(''); Its latest announcement in the Borme was published on 04/04/2023 Southbound: Kadoma exit, 1 minute' walk from Nihonbashi exit of Tokyo Station, JR Line With our dedication to customer service, on-time delivery, reliable supply and quality manufacturing, we improve the health and lives of the patients we and our customers serve. de 2021 - actualidad2 aos 5 meses Leadership: Develop the strategic sourcing of the global spend delivering all BU's requirements Lead and motivate. (Osaka, Japan) (TOWA) and ESTEVE (Barcelona, Spain) announced today that TOWA will acquire 100% ownership of Pensa Investments, S.L. Berlin, CT 06037. document.write(addy22534); PTS Consulting, LLC and PTS Pharma LLC., is a formulation development, clinical trial production, regulatory services and analytical control laboratory based in Kansas. In 2020 Towa Pharmaceutical became international by adding Towa International business, and we became its major company who operates worldwide within a platform of an R&D center, innovative production capabilities, and direct commercial presence in Europe and the United States of America. Your use of this website is also subject to our Terms of Use and Privacy Policy. By acquiring Pensa, TOWA will be able to provide high-quality and value-added generic medicines to patients, not only in Japan but also abroad, by using a manufacturing factory that specializes in pellet preparation in Spain as well as its network of subsidiary companies in Europe and the United States. As a brand, it is recognised and valued by patients and has a strong presence in the market. Premium quality track record and Quality by Design is our mindset. From these locations, and through strategic alliances, we reach patients in more than 30 countries. We generated genuine smiles. We are building a global business to provide patients around the world with high-quality and high added value medicines and to support the sustainability of health systems. generic, value-added medicines, and OTC company in Europe. Your email will not be given to 3rd parties. Towa Pharma Portugal | 1,026 followers on LinkedIn. By providing your email address you consent to being contacted by email for direct marketing purposes by Informa Markets. //-->\n Breckenridge received final approval for the 60mg/1.5mL (40mg/mL) strength. The Company's products are registered in more than eight countries and its manufacturing facilities are complying with various regulatory authorities from Asia, Latin America, Middle East, Africa, etc. //--> He heads Towa international business since 2019 and his priorities are to expand Towas presence in the US and European markets by providing value added medicines to the patients worldwide. Breckenridge Pharmaceutical, Inc. announces today that it has signed a new-product agreement with PTS Pharma, LLC. This email address is being protected from spambots. Cookie Policy David Peix has been involved in the generic pharmaceutical industry for over eight years. Breckenridge has the three strengths consistent with the brand 75mg, 110mg, and 150mg. The corporation may be a business or a nonprofit organization. addy67623 = addy67623 + 'igbamedicines' + '.' + 'org'; The firm was founded in 2003 by Paul Sudhakar, an industry veteran who is the Owner, President, and CEO of the firm. ESTEVE's Chief Executive Officer, Staffan Schberg, commented: ''TOWA is undoubtedly the ideal partner to develop the full potential of the ESTEVE generic division. Important: If you continue, the information you are about to access may not comply with local regulatory requirements in your country. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Experience in food company in Greece. var path = 'hr' + 'ef' + '='; We have the ability to support our customers processes at any stage of oral products lifecycle, from development stage up to manufacturing and packaging activities.All those steps are delivered through high quality GMP standards and supported by a strong supply chain model. document.write('span>'); Number 8860726.